Serum Matrix Metalloproteinase-2 as a Prognostic Marker in Advanced Cutaneous Melanoma

By Vuoristo Meri-Sisko   Kellokumpu-Lehtinen Pirkko   Parvinen Leena-Maija   Hahka-Kemppinen Marjo   Korpela Merja   Kumpulainen Eero   Laine Seppo  

Acta Oncologica, Vol. 39, Iss. 7, 2000-11 ,pp. : 877-879

Informa Healthcare

Access to resources Recommend Favorite

Acute Effects of Pamidronate Administration on Serum Levels of Interleukin-6 in Advanced Solid Tumour Patients with Bone Metastases and their Possible Implications in the Immunotherapy of Cancer with Interleukin-2

By Lissoni P.   Cazzaniga M.   Barni S.   Perego M.S.   Brivio F.   Fumagalli L.   Tancini G.  

European Journal of Cancer, Vol. 33, Iss. 2, 1997-02 ,pp. : 304-306

Elsevier

Access to resources Recommend Favorite

The Prognostic Value of Serum and Immunohistochemical Tumour Markers in Advanced Gastric Cancer

By Webb A.   Scott-Mackie P.   Cunningham D.   Norman A.   Andreyev J.   O'Brien M.   Bensted J.  

European Journal of Cancer, Vol. 32, Iss. 1, 1996-01 ,pp. : 63-68

Elsevier

Access to resources Recommend Favorite

Evaluation of EMMPRIN and MMP-2 in the prognosis of primary cutaneous malignant melanoma

By Chen Tiefu  

Medical Oncology, Vol. 27, Iss. 4, 2010-12 ,pp. : 1185-1191

Humana Press, Inc

Access to resources Recommend Favorite

Home Therapy with Autologous Tumour-infiltrating Lymphocytes and Subcutaneous Interleukin-2 in Metastatic Melanoma

By Tessier M.-H.   Pandolfino M.-C.   Jotereau F.   Boudart D.   Litoux P.   Dreno B.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 735-736

Elsevier

Access to resources Recommend Favorite